Nymox Announces Closing Of $6.4 Million Financing
04/04/22, 9:45 AM
Location
Money raised
$6.4 million
Nymox Pharmaceutical Corporation (NASDAQ: NYMX) (the “Company”) is pleased to announce that it has closed its $6.4 million financing announced in its filing of March 22 with institutional and accredited investors consisting of 3,878,789 common shares at a purchase price of $1.65 per share, sold pursuant to a registered direct offering. The Company has also issued to the investors, in a concurrent private placement, unregistered warrants to purchase up to an aggregate of 3,878,789 common shares. The warrants have an exercise price of $2.00 per share and will expire 5 years from the date of an effective registration statement covering the shares underlying the warrants.
Company Info
Location
irvine, california, united states
Additional Info
Nymox is also pleased to report that the offering has the strong support of long-term shareholders and would like to thank one of our Directors, James G. Robinson for his participation in the offering, consisting of 1,151,515 units ($1.9 million).